Single-cell atlas of pig-to-monkey kidney xenotransplantation reveals macrophage chimerism and an IFN-ε orchestrated graft protective immune niche

This study presents a single-cell atlas of pig-to-monkey kidney xenotransplantation that reveals macrophage chimerism and identifies an epithelial-derived IFN-ε axis as a critical orchestrator of a graft-protective immune niche, offering new insights into xenograft adaptation and potential therapeutic targets.

The Gist

Imagine you are trying to transplant a heart from a pig into a human. It sounds like science fiction, but scientists are working hard to make it real to solve the global shortage of human organs. However, the human body is like a highly trained security team that immediately attacks anything foreign. This is called rejection.

This paper is like a high-definition, slow-motion video of what happens inside a pig kidney when it's placed into a monkey (a close relative of humans) during the first few days of the transplant. The researchers used a powerful new technology called single-cell sequencing to look at every single cell in the kidney, rather than just looking at the tissue as a blurry whole.

Here is the story of what they found, explained simply:

1. The Security Guard Overload (Macrophages)

Usually, when we think of immune rejection, we imagine "soldier" T-cells attacking the new organ. But in this study, the researchers found that the real troublemakers were the Macrophages.

Think of Macrophages as the janitors and security guards of the body. Their job is to clean up trash and patrol for intruders.

• The Problem: In the pig kidney, the monkey's security guards (macrophages) flooded in, overwhelming the organ. They were so numerous they outnumbered the kidney's own cells.
• The Twist: The researchers found two distinct groups of these guards:
  • The "Bad" Guards (Donor): The pig's own guards were confused and dying. They were shouting "Help!" and causing inflammation.
  • The "Invading" Guards (Recipient): The monkey's guards took over. Some were aggressive attackers, but surprisingly, some were actually trying to be peacemakers.

2. The "Hybrid" Guards

In the past, scientists thought immune cells were either "Good" (anti-inflammatory) or "Bad" (pro-inflammatory). This study found that these guards were hybrids.

Imagine a security guard who is simultaneously holding a fire extinguisher (trying to put out the fire) and a flamethrower (accidentally starting one). These cells were switching back and forth, trying to adapt to the chaotic environment of the transplant. They weren't just one thing; they were a complex mix of both, trying to survive the stress.

3. The Kidney's Secret Weapon: The "Peacekeeper" Signal

This is the most exciting discovery. The researchers found that the pig kidney cells themselves weren't just sitting there waiting to die. They were fighting back!

Specifically, the kidney cells started producing a special chemical signal called IFN-ε (Interferon-epsilon).

• The Analogy: Imagine the pig kidney is a castle under siege. Instead of just building higher walls, the castle sends out a specific radio broadcast (IFN-ε) that says, "Hey, you aggressive guards, stand down! We have a truce."
• The Result: This signal specifically recruited a special group of the monkey's guards (called IDO1+ macrophages) to stop attacking and start protecting the kidney. It created a tiny "safe zone" or a peaceful neighborhood inside the war zone, trying to save the graft.

4. The "Wanted" List for New Drugs

Because the researchers could see exactly which cells were causing the most damage, they could predict which existing drugs might work.

• They identified three specific types of "Bad Guards" causing the most trouble.
• They ran a computer simulation to see which FDA-approved drugs could target these specific guards.
• The Winners: They found three candidates: Belatacept, Abatacept, and Pexidartinib.
  • Think of these as specialized handcuffs or sedatives that could calm down the specific angry guards without shutting down the whole immune system.

5. The Big Picture: A War of Two Signals

The paper suggests that the fate of a transplanted organ depends on a tug-of-war between two forces:

1. The Attack Signal (IFN-γ): The standard immune system screaming "Intruder! Attack!"
2. The Peace Signal (IFN-ε): The kidney's own secret signal screaming "Stand down! We are friends!"

In this experiment, the "Attack" signal was winning, which is why the kidneys eventually failed. But the discovery of the "Peace" signal gives scientists a new roadmap. If we can boost the kidney's "Peace Signal" or use the new drugs to stop the "Attack," we might be able to keep pig organs alive in humans for a long time.

Summary

This paper is a molecular map of a transplant battle. It shows us that:

• The immune system is more complex than we thought (guards can be hybrids).
• The organ itself tries to negotiate peace (via IFN-ε).
• We have a new list of drugs that might finally make pig-to-human transplants a safe, long-term reality.

It's like realizing that in a massive riot, the police aren't just attacking; some are trying to negotiate, and the building itself is waving a white flag. If we can help the negotiators win, we can save the building.

Technical Summary

1. Problem Statement

The clinical translation of xenotransplantation (using pig organs for humans) is currently hindered by an incomplete understanding of the cellular and molecular mechanisms governing graft rejection versus adaptation. While brain-dead decedent (BDD) models have provided initial insights, they suffer from confounding systemic inflammation, cytokine storms, and the inability to assess long-term adaptive immunity or chronic rejection. There is a critical need for a high-resolution, physiologically intact preclinical model to decipher the specific immune circuitry driving xenograft failure and to identify actionable therapeutic targets.

2. Methodology

The study employed a pig-to-rhesus macaque kidney xenotransplantation model combined with single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics.

• Experimental Model:
  • Donors: Two $\alpha$-galactosyltransferase (GGTA1) monoallelic knockout Bama miniature pigs.
  • Recipients: Two male rhesus macaques (10–11 years old).
  • Immunosuppression: A clinically mimetic dual-phase regimen including induction (basiliximab, methylprednisolone, rituximab) and maintenance (mycophenolate mofetil, tapered corticosteroids, cyclosporine A).
  • Endpoints: Kidneys were harvested at terminal rejection (Day 7 and Day 11) and compared against untransplanted control pig kidneys.
• Omics and Analysis:
  • scRNA-seq: Generated a high-resolution atlas of ~75,324 high-quality cells.
  • Species Deconvolution: Reads were independently aligned to porcine and monkey genomes to distinguish donor-resident vs. recipient-infiltrating cells.
  • Computational Tools: Used Seurat for clustering, Monocle2 for pseudotemporal trajectory analysis, CellPhoneDB for ligand-receptor (L-R) interaction mapping, and pySCENIC for transcription factor activity inference.
  • Drug Repurposing: Utilized the drug2cell algorithm to predict FDA-approved compounds targeting specific pathogenic subsets.
  • Validation: Immunohistochemistry (IHC) and multiplexed immunofluorescence (IF) were used to validate protein expression and cellular localization.

3. Key Contributions

• First High-Resolution Atlas: Established the first single-cell transcriptomic atlas of pig-to-non-human primate (NHP) kidney xenotransplantation, capturing early immune dynamics prior to graft loss.
• Macrophage Chimerism: Defined a "chimeric" myeloid landscape where graft rejection is driven by a complex interplay between donor-resident (tissue-resident) and recipient-infiltrating macrophage subsets, each with distinct transcriptional programs.
• IFN-ε Orchestration: Discovered a novel, graft-protective immune niche orchestrated by epithelial-derived Interferon-epsilon (IFN-ε), which recruits immunosuppressive macrophages to counteract systemic rejection signals.
• Therapeutic Prediction: Identified specific drug candidates (belatacept, abatacept, pexidartinib) based on the transcriptional profiles of pathogenic macrophage subsets.

4. Key Results

A. Innate Immune Dominance and Macrophage Chimerism

• Innate Shift: Despite immunosuppression targeting adaptive immunity, the graft microenvironment was dominated by innate immune cells, specifically macrophages.
• Dual Origin:
  • Recipient-Derived: Enriched for subsets expressing ACKR1+, FN1+, MARCO+, and IDO1+. These cells exhibited hybrid M1/M2 states and high expression of immune checkpoint molecules.
  • Donor-Resident: Included APOE+, CCL2+, IL-1A+, SLPI+, WFDC2+, and CCL5+ subsets. These showed pro-inflammatory signatures but suffered from functional impairment (cell cycle arrest) under xenogeneic stress.
• Hybrid Polarization: Both donor and recipient macrophages deviated from the classical binary M1/M2 dichotomy, adopting hybrid states (e.g., M2-dominant with persistent M1-associated inflammatory damage) driven by specific transcription factors (e.g., STAT3, TWIST1, NR1H3).

B. Pathogenic Subsets and Therapeutic Targets

• Pro-Inflammatory Drivers: Three donor-derived macrophage subsets (APOE+, CCL2+, IL-1A+) were identified as the primary drivers of inflammation, expressing high levels of Type 1 cytokines (TNF, IL-1A/B, IL-6).
• Drug Prediction: Computational screening identified Belatacept/Abatacept (CD80/86-CD28 blockers) and Pexidartinib (CSF1R inhibitor) as promising candidates. These drugs target the specific receptors (CD80/86, CSF1R) highly expressed on the pathogenic macrophage subsets, suggesting a need to simultaneously block T-cell co-stimulation and deplete macrophages.

C. The IFN-ε Orchestrated Protective Niche

• Epithelial Signaling: Unlike the canonical pro-inflammatory IFN-$\gamma$ pathway (which was downregulated in tubular cells), IFN-ε was significantly upregulated in Distal Tubule (DT) epithelial cells.
• Protective Circuit: IFN-ε+ DT cells engaged in specific crosstalk with recipient-derived IDO1+ macrophages.
• Mechanism: This interaction recruits IDO1+ macrophages, which utilize tryptophan metabolism to suppress T-cell function, creating a localized immune-tolerant niche that counteracts systemic rejection. This suggests the graft epithelium actively participates in immune modulation.

D. Cell-Cell Communication Networks

• Macrophage Hubs: Macrophages acted as central signaling hubs, interacting with all major cell types.
• Dual Axes: The network bifurcated into:
  1. Pro-inflammatory Axis: Mediated by IL1B, TNF, and complement pathways (C3, CD93).
  2. Regulatory Axis: Mediated by TGF-$\beta$, IL-10, and lipid signaling (PGE2, cholesterol derivatives) that promoted M2 polarization and tissue repair.
• Lipid Signaling: Communication between donor and recipient macrophages was predominantly mediated by lipid molecules (e.g., PGE2, LXA4), highlighting metabolic reprogramming as a key regulatory mechanism.

E. Lymphocyte Dynamics

• Depletion: B cells were nearly depleted (consistent with Rituximab use).
• T Cell Heterogeneity: CD8+ T cells exhibited a bifurcated trajectory: one branch leading to cytotoxic dysfunction (LAG3+, TIGIT+) and another to an exhausted/regulatory state (PDCD1+, CTLA4+, IL-10+).
• Th2 Polarization: The CD4+ compartment was exclusively Th2-polarized (GATA3+), potentially driven by specific immunosuppressive regimens.

5. Significance and Implications

• Paradigm Shift: The study challenges the binary view of "rejection vs. tolerance," proposing a dynamic conflict between systemic IFN-$\gamma$-driven attack and local IFN-ε-driven protection.
• Therapeutic Strategy: It highlights that successful xenotransplantation requires dual targeting: blocking adaptive T-cell co-stimulation (Belatacept) while simultaneously depleting or reprogramming pathogenic macrophages (Pexidartinib).
• Donor Engineering: The findings suggest that engineering donor organs to enhance IFN-ε expression or recruit IDO1+ macrophages could be a novel strategy to induce local tolerance.
• Model Validation: The NHP model proved superior to BDD models in capturing the nuanced, active role of graft epithelium in immune regulation, free from brain-death confounders.

Limitations Noted: The study used only GGTA1-knockout pigs (lacking other critical edits like CD46/CD47), had a small sample size (n=2), and short follow-up times, limiting the assessment of chronic rejection mechanisms. Future work requires multi-gene-edited models and longer survival studies.